Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial” or the "Company”), a clinical-stage biopharmaceutical company focused on ...

The U.S. Food and Drug Administration (FDA) has cleared an investigational new drug application from FluoGuide A/S in Copenhagen, Denmark, allowing the company to move forward in the U.S. with a ...

What Businesses Should Know About Deconstruction Opportunities in the Coming Weeks St Louis, United States - February ...

Compass Pathways announced that its investigational psilocybin treatment has successfully met its primary endpoint in a Phase 3 trial in depression.

A new publication DOI 10.29026/oes.2026.250031, discusses an integrated metasurface-freeform system enabled multi-focal ...

Greece has completed 53% of EU Recovery Fund milestones, securing €23.4B so far as the August 2026 deadline approaches.

Q4 2025 Earnings Call February 18, 2026 7:00 PM ESTCompany ParticipantsKevin Burke - President, CEO & ChairmanJeffrey ...

Upon exercise of the option and completion of the acquisition, AlphaTON would be entitled to an upfront cash payment at closing, equity consideration representing 10% of the fully diluted equity of ...

Cheaper flights are fueling a surge in travel demand, just as spring break season ramps up. Recent data from KAYAK shows that ...

The Apollo missions changed how scientists understand the moon. Returning with Artemis could help solve some of the biggest ...

Operator: Good morning, and thank you for joining us today. This morning, Donegal Group Inc. issued its fourth quarter and ...

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.